Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis.

PURPOSE The incidence of multifocality of papillary thyroid carcinoma (PTC) ranges from 18 to 87.5% The mechanisms of multifocal spreading, correlation with tumor size, histology variants of PTC, lymph node metastases, and prognostic impact remains unclear. The purpose of this study was to clarify the prognostic significance of multifocality on relapse and survival rates of patients with PTC by analyzing the correlation of multifocality with patient age, gender, tumor size, histological variants of PTC, presence of lymph node metastases and extent of surgery. METHODS 153 patients with PTC were included in this study. Patients with pT4 tumors or initially distant metastases were excluded from study. Total thyroidectomy was done in all 153 patients. Central and level III and IV lateral neck lymph node dissection was done in 76.5% of the patients, followed by modified radical neck dissection if positive. RESULTS Multifocality was found in 43 (28%) whole thyroid gland specimens, and was significantly more frequent in patients older than 45 years and in tumors greater than 4 cm in diameter (p<0.01). Presence of multifocality didn't significantly correlate with gender, histology variants of PTC or lymph node metastases. In a median follow up of 84 months locoregional relapse occurred in 8.4% and 1.3% of the patients, while 7.2% patients died due to PTC. The incidence of relapse was significantly higher (p<0.01), and relapse free interval and survival were significantly shorter (p=0.0095, p=0.0004, respectively) in patients with multifocal PTC. Cox multivariate regression analysis showed that multifocality was independent prognostic factor for both disease-free interval (DFI) and cancer-specific survival (CSS) of patients with PTC. CONCLUSION Due to high incidence of multifocality and potential prognostic impact, total thyroidectomy should be advocated in all patients with PTC, aiming to reduce relapse rate and improve DFI and CSS.

[1]  C. Hsueh,et al.  Prognosis of Multifocal Papillary Thyroid Carcinoma , 2013, International journal of endocrinology.

[2]  A. Alfonso,et al.  Multifocal Micropapillary Thyroid Cancer: A New Indication for Total Thyroidectomy? , 2012, The American surgeon.

[3]  G. Poissonnet,et al.  Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. , 2012, European annals of otorhinolaryngology, head and neck diseases.

[4]  P. Ladenson,et al.  Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. , 2005, The New England journal of medicine.

[5]  Macp,et al.  Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  S. Asa,et al.  Clonality of thyroid nodules in sporadic goiter. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[7]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[8]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[9]  M. Bäckdahl,et al.  Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. , 1992, Surgery.

[10]  E. Kaplan,et al.  Second operations for "completion" of thyroidectomy in treatment of differentiated thyroid cancer. , 1991, Surgery.

[11]  J. Chabot,et al.  The intraoperative incidence of detectable bilateral and multicentric disease in papillary cancer of the thyroid. , 1990, Surgery.

[12]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[13]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[14]  E. White,et al.  Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands , 1963, Cancer.

[15]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[16]  Yasuhiro Ito,et al.  Lymph node metastases in clinically N0 patients with papillary thyroid microcarcinomas - a single institution experience. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[17]  W. Chung,et al.  Prognostic Significance of Tumor Multifocality in Papillary Thyroid Carcinoma and its Relationship with Primary Tumor Size: A Retrospective Study of 2,309 Consecutive Patients , 2014, Annals of Surgical Oncology.

[18]  I. Hay,et al.  Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. , 2002, Transactions of the American Clinical and Climatological Association.

[19]  G. Brabant,et al.  in Human Thyroid Carcinomas: Implications Human Thyroid , 1997 .